The panel will discuss the effect of the patent litigation provisions in the recently passed Biosimilars Act. 1.5 hours of CLE credit will be offered.

The panelists will be:

• Robin Cooper Feldman, Professor of Law; Director, Law and Bioscience Project, UC Hastings College of the Law
• Jennifer Flory, Intellectual Property Counsel, Hospira
• Gary Loeb, Vice President Intellectual Property, Genentech
• Bruce Leicher, Senior Vice President and General Counsel, Momenta Pharmaceuticals, Inc.
• Jessica Wolff, Partner, Intellectual Property Group, Cooley LLP

Registration for this event is complimentary. Please register your attendance at:

http://www.stanford.edu/dept/law/forms/biosimilars.fb